Claims
- 1. A monoclonal antibody which is selected from a group consisting of 3E3, 4H8 and 5G2, and is capable of detecting metabolites of Bowman-Birk protease inhibitor in a body fluid or tissue, said antibodies produced by hybidoma cell lines with ATCC designation number HB-12180, HB-12179, and HB-12178, respectively.
- 2. A hybridoma cell line producing monoclonal antibody 3E3, and having ATCC designation number HB-12180.
- 3. A hybridoma cell line producing monoclonal antibody 4H8, and having ATCC designation number HB-12179.
- 4. A hybridoma cell line producing monoclonal antibody 5G2, and having ATCC designation number HB-12178.
Parent Case Info
This is a division of application Ser. No. 08/358,265, filed Dec. 19, 1994.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5459044 |
Brandon et al. |
Oct 1995 |
|
Non-Patent Literature Citations (1)
Entry |
Madar, Z. et al. 1979. Comp. Biochem. physiol. 62A: 1057-1061. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
358265 |
Dec 1994 |
|